Lewy body (LB)
Interleukin-1 mediates Alzheimer and Lewy body pathologies
9
TIGAR inclusion pathology is specific for Lewy body diseases
47
Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease
5
Alpha-synuclein biology in Lewy body diseases
9
Lewy Body Dementia (Update)
42
Intra neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases
12
Characteristics of facial expression recognition ability in patients with Lewy body disease
7
Compensatory shifts in visual perception are associated with hallucinations in Lewy body disorders
9
Advocacy, education, and the role of not-for-profit organizations in Lewy body dementias
5
Lewy body dementia: the impact on patients and caregivers
7
Tyrosine hydroxylase and Lewy body molecules immunoreactivity in the SNC neurons of an AS/AGU mutantrat
6
Differential expression of galanin in the cholinergic basal forebrain of patients with Lewy body disorders
12
Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly
9
MRI of the Swallow Tail Sign: A Useful Marker in the Diagnosis of Lewy Body Dementia?
5
<p>Cognitive Impairment in Parkinson’s Disease: What We Know so Far</p>
11
New α- and γ-synuclein immunopathological lesions in human brain
9
APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
14
Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria
14
APOE ɛ4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
47
Clinical prevalence of Lewy body dementia
8